{"id":30,"date":"2020-08-18T14:46:05","date_gmt":"2020-08-18T18:46:05","guid":{"rendered":"https:\/\/scholarrock301.wpengine.com\/?page_id=30"},"modified":"2023-02-13T14:12:56","modified_gmt":"2023-02-13T19:12:56","slug":"oncology","status":"publish","type":"page","link":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/","title":{"rendered":"Oncology"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"30\" class=\"elementor elementor-30\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-578d13d srk-015-row top-row narrow-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"578d13d\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0285a25\" data-id=\"0285a25\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-5a86241 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5a86241\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-38566cc\" data-id=\"38566cc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8236e3c elementor-widget elementor-widget-text-editor\" data-id=\"8236e3c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>We believe SRK-181 has the potential to meaningfully increase the benefit as well as the number of patients who could benefit from immunotherapies by rendering resistant solid tumors vulnerable to immune checkpoint inhibitors such as anti-PD-1\/PD-L1 therapies.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-cb2f16e\" data-id=\"cb2f16e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-02198a9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"02198a9\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-07776d9\" data-id=\"07776d9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bb68297 half-col-image elementor-widget elementor-widget-image\" data-id=\"bb68297\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"836\" height=\"754\" src=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png\" class=\"attachment-full size-full wp-image-734\" alt=\"Jar of liquid on counter in lab\" srcset=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png 836w, https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image-300x271.png 300w, https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image-768x693.png 768w\" sizes=\"(max-width: 836px) 100vw, 836px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-a9ebb62\" data-id=\"a9ebb62\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f1b90fc card green-card assets elementor-widget elementor-widget-text-editor\" data-id=\"f1b90fc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Assets<\/h2>\n<h3>SRK-181 (Selective context-independent, anti-latent TGF\u03b2-1)<\/h3>\n<p><a class=\"text-button\" href=\"\/our-pipeline\/\">See Our Progress<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c77b7f3 elementor-widget elementor-widget-text-editor\" data-id=\"c77b7f3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>While anti-PD-(L)1 therapies have revolutionized the treatment of patients with cancer, this therapeutic approach is only effective in a small subset of patients. This has led to a deluge of efforts to evaluate checkpoint inhibitors in combination therapy settings in order to overcome tumor resistance. This race to find the \u201cright\u201d combination therapy has been met with disappointing clinical results and failures as successes in preclinical models fail to translate to successful clinical trials.<\/p><blockquote><p>True to the Scholar Rock way, we have taken a closer look and a different approach. We have applied knowledge gained from retrospective analyses of human tumors and therapeutic response data to our selection of preclinical models, which we believe, more appropriately reflect human tumor biology.\u00a0<\/p><\/blockquote><p>In preclinical studies, we demonstrated that targeting the precursor, or latent, form of the TGF\u03b21 growth factor can render tumors vulnerable to anti-PD1 therapy and drive tumor regression through combination therapy.\u00a0 This was demonstrated across multiple mouse models that reflect resistance to anti-PD-1 treatment, including melanoma, urothelial carcinoma, and breast cancer. By specifically targeting the TGF\u03b21 isoform and sparing the TGF\u03b22 and TGF\u03b23 isoforms, which are thought to be involved in functions such as cardiac homeostasis, we have also observed an improved preclinical safety profile compared to non-selective approaches.<\/p><p>We are investigating SRK-181, a selective inhibitor of latent TGF\u03b21 activation, in the DRAGON Phase 1 clinical trial in patients with locally advanced or metastatic solid tumors.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-09b5da3 immune-checkpoints-row dark-green-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"09b5da3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4fcfd78\" data-id=\"4fcfd78\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-46c1f60 elementor-widget elementor-widget-text-editor\" data-id=\"46c1f60\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Immune Checkpoints: A Closer Look<\/h2>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-ba8571b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ba8571b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-wider\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-c5ad77d\" data-id=\"c5ad77d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3641a1b elementor-widget elementor-widget-text-editor\" data-id=\"3641a1b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>A growing body of clinical and preclinical evidence has implicated TGF\u03b21 as a key culprit in driving primary resistance to anti-PD-(L)1 therapy. In one example, Genentech published the results of a study identifying an association between increased TGF\u03b2 signaling with impaired tumor responses and reduced survival from anti-PD-L1 antibody therapy in patients with metastatic urothelial cancer. We have further explored this topic by analyzing a database of thousands of molecularly characterized tumor samples and identified TGF\u03b21 as the predominant TGF\u03b2 isoform in many human tumors.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-28e33aa\" data-id=\"28e33aa\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0befe82 elementor-widget elementor-widget-text-editor\" data-id=\"0befe82\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>However, TGF\u03b2 has historically proved to be a challenging drug target. Traditional approaches broadly inhibit the signaling of all three TGF\u03b2 isoforms (TGF\u03b21, TGF\u03b22, and TGF\u03b23). The lack of selectivity amongst the different isoforms has resulted in on-target toxicities, most notably cardiovascular side effects. At Scholar Rock, we are developing SRK-181, a monoclonal antibody with high selectivity for specifically the TGF\u03b21 isoform, which we believe may lead to a more favorable safety profile (and potentially enable a wider therapeutic window) and therefore be better suited to combination therapy.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3359bb3 elementor-section-stretched clinical-trials-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3359bb3\" data-element_type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-eee023b\" data-id=\"eee023b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2d3b45e card elementor-widget elementor-widget-text-editor\" data-id=\"2d3b45e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Clinical Trials<\/h2><p><a href=\"https:\/\/scholarrock.com\/\/wp-content\/uploads\/2020\/10\/dragon.svg\"><img decoding=\"async\" class=\"alignleft wp-image-884\" src=\"https:\/\/scholarrock.com\/\/wp-content\/uploads\/2020\/10\/dragon.svg\" alt=\"Dragon Logo\" width=\"150\" height=\"150\" \/><\/a>DRAGON is evaluating the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of SRK-181 in patients with locally advanced or metastatic solid tumors.<\/p><p><a class=\"text-button\" href=\"\/our-pipeline\/clinical-trials\/\">Learn More About the DRAGON Clinical Trial<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6bd32d5 elementor-widget elementor-widget-text-editor\" data-id=\"6bd32d5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Expanded Access Policy<\/h2><p><a class=\"text-button\" href=\"\/expanded-access-policy\/\">View Our Expanded Access Policy<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-587d280 elementor-section-content-middle narrow-row elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-phone elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"587d280\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-840485d\" data-id=\"840485d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8ca3d2a elementor-widget elementor-widget-text-editor\" data-id=\"8ca3d2a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Patients First<\/h2>\n<p>Patients first; everything else second. We connect patients and families to trusted oncology advocacy groups to support their wellbeing holistically.<\/p>\n<p><a class=\"text-button\" href=\"\/patients-families\/\">Find Patient Advocacy Groups for Oncology<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-a219635\" data-id=\"a219635\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e017cb9 half-col-image elementor-widget elementor-widget-image\" data-id=\"e017cb9\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"724\" height=\"676\" src=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/patients-first-woman.png\" class=\"attachment-full size-full wp-image-732\" alt=\"Middle aged white woman with blue hair\" srcset=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/patients-first-woman.png 724w, https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/patients-first-woman-300x280.png 300w\" sizes=\"(max-width: 724px) 100vw, 724px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4b9fd01 floating-patients-first-image elementor-widget elementor-widget-image\" data-id=\"4b9fd01\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"550\" height=\"514\" src=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/patients-first-woman-dog.png\" class=\"attachment-full size-full wp-image-731\" alt=\"Young smiling black woman holding a small white dog\" srcset=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/patients-first-woman-dog.png 550w, https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/patients-first-woman-dog-300x280.png 300w\" sizes=\"(max-width: 550px) 100vw, 550px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e786da8 elementor-section-stretched other-areas-of-exploration-row green-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e786da8\" data-element_type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-660486d\" data-id=\"660486d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b8076c7 h2-small elementor-widget elementor-widget-text-editor\" data-id=\"b8076c7\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Learn more about our other areas of Exploration<\/h2>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-cc71762 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"cc71762\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-inner-column elementor-element elementor-element-6d9b9a3 disease-state-card sma\" data-id=\"6d9b9a3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b8ec383 disease-state-name oncology elementor-widget elementor-widget-text-editor\" data-id=\"b8ec383\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h3>Spinal Muscular<br \/>Atrophy<\/h3>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ceed143 elementor-widget elementor-widget-text-editor\" data-id=\"ceed143\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><a href=\"\/our-pipeline\/spinal-muscular-atrophy\/\">Click to Learn More<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-inner-column elementor-element elementor-element-5b60605 disease-state-card ira\" data-id=\"5b60605\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9f00361 disease-state-name ira elementor-widget elementor-widget-text-editor\" data-id=\"9f00361\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h3>Anemias<\/h3>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6b5b5b5 elementor-widget elementor-widget-text-editor\" data-id=\"6b5b5b5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><a href=\"\/our-pipeline\/anemia\/\">Click to Learn More<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-inner-column elementor-element elementor-element-aeff44b disease-state-card fibrosis\" data-id=\"aeff44b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f1b84c8 disease-state-name fibrosis elementor-widget elementor-widget-text-editor\" data-id=\"f1b84c8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h3>Fibrosis<\/h3>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-92f1da6 elementor-widget elementor-widget-text-editor\" data-id=\"92f1da6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><a href=\"\/our-pipeline\/fibrosis\/\">Click to Learn More<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>We believe SRK-181 has the potential to meaningfully increase the benefit as well as the number of patients who could benefit from immunotherapies by rendering resistant solid tumors vulnerable to immune checkpoint inhibitors such as anti-PD-1\/PD-L1 therapies. Assets SRK-181 (Selective context-independent, anti-latent TGF\u03b2-1) See Our Progress While anti-PD-(L)1 therapies have revolutionized the treatment of patients [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":26,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"class_list":{"0":"post-30","1":"page","2":"type-page","3":"status-publish","5":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SRK-181 for Oncology &amp; Immuno-Oncology - Scholar Rock<\/title>\n<meta name=\"description\" content=\"A potent and highly selective inhibitor of latent TGF\u03b2 activation, SRK-181 has potential to benefit many oncology patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SRK-181 for Oncology &amp; Immuno-Oncology - Scholar Rock\" \/>\n<meta property=\"og:description\" content=\"A potent and highly selective inhibitor of latent TGF\u03b2 activation, SRK-181 has potential to benefit many oncology patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Scholar Rock\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-13T19:12:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ScholarRock\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/\",\"url\":\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/\",\"name\":\"SRK-181 for Oncology & Immuno-Oncology - Scholar Rock\",\"isPartOf\":{\"@id\":\"https:\/\/scholarrock.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png\",\"datePublished\":\"2020-08-18T18:46:05+00:00\",\"dateModified\":\"2023-02-13T19:12:56+00:00\",\"description\":\"A potent and highly selective inhibitor of latent TGF\u03b2 activation, SRK-181 has potential to benefit many oncology patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#primaryimage\",\"url\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png\",\"contentUrl\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png\",\"width\":836,\"height\":754,\"caption\":\"Jar of liquid on counter in lab\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/scholarrock.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Pipeline\",\"item\":\"https:\/\/scholarrock.com\/our-pipeline\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/scholarrock.com\/#website\",\"url\":\"https:\/\/scholarrock.com\/\",\"name\":\"Scholar Rock\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/scholarrock.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/scholarrock.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/scholarrock.com\/#organization\",\"name\":\"Scholar Rock\",\"url\":\"https:\/\/scholarrock.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg\",\"contentUrl\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Scholar Rock\"},\"image\":{\"@id\":\"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ScholarRock\",\"https:\/\/www.linkedin.com\/company\/scholar-rock\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SRK-181 for Oncology & Immuno-Oncology - Scholar Rock","description":"A potent and highly selective inhibitor of latent TGF\u03b2 activation, SRK-181 has potential to benefit many oncology patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/","og_locale":"en_US","og_type":"article","og_title":"SRK-181 for Oncology & Immuno-Oncology - Scholar Rock","og_description":"A potent and highly selective inhibitor of latent TGF\u03b2 activation, SRK-181 has potential to benefit many oncology patients.","og_url":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/","og_site_name":"Scholar Rock","article_modified_time":"2023-02-13T19:12:56+00:00","og_image":[{"url":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png"}],"twitter_card":"summary_large_image","twitter_site":"@ScholarRock","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/","url":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/","name":"SRK-181 for Oncology & Immuno-Oncology - Scholar Rock","isPartOf":{"@id":"https:\/\/scholarrock.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#primaryimage"},"image":{"@id":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png","datePublished":"2020-08-18T18:46:05+00:00","dateModified":"2023-02-13T19:12:56+00:00","description":"A potent and highly selective inhibitor of latent TGF\u03b2 activation, SRK-181 has potential to benefit many oncology patients.","breadcrumb":{"@id":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/scholarrock.com\/our-pipeline\/oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#primaryimage","url":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png","contentUrl":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/oncology-image.png","width":836,"height":754,"caption":"Jar of liquid on counter in lab"},{"@type":"BreadcrumbList","@id":"https:\/\/scholarrock.com\/our-pipeline\/oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/scholarrock.com\/"},{"@type":"ListItem","position":2,"name":"Our Pipeline","item":"https:\/\/scholarrock.com\/our-pipeline\/"},{"@type":"ListItem","position":3,"name":"Oncology"}]},{"@type":"WebSite","@id":"https:\/\/scholarrock.com\/#website","url":"https:\/\/scholarrock.com\/","name":"Scholar Rock","description":"","publisher":{"@id":"https:\/\/scholarrock.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/scholarrock.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/scholarrock.com\/#organization","name":"Scholar Rock","url":"https:\/\/scholarrock.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/","url":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg","contentUrl":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg","width":1,"height":1,"caption":"Scholar Rock"},"image":{"@id":"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ScholarRock","https:\/\/www.linkedin.com\/company\/scholar-rock\/"]}]}},"_links":{"self":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages\/30","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/comments?post=30"}],"version-history":[{"count":0,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages\/30\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages\/26"}],"wp:attachment":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/media?parent=30"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}